Meidan F. Ying
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 102 publications
LECT2-RPS27A interaction involving Lys48 attenuates neuroinflammation in diabetic retinopathy.
Journal: Diabetologia
Published: April 15, 2026
Advances in targeted therapies for pediatric tumors.
Journal: Acta pharmacologica Sinica
Published: January 08, 2026
Discovery of DN1679 as a Potent, Orally Bioavailable, and Highly Selective CDK12/13 Dual Degrader for the Treatment of Triple-Negative Breast Cancer.
Journal: Journal of medicinal chemistry
Published: December 31, 2025
Targeting fusion proteins in solid tumors: from oncogenic mechanisms to clinical interventions.
Journal: Acta pharmacologica Sinica
Published: October 02, 2025
Palmitic acid activates c-Myc via dual palmitoylation-dependent pathways to promote colon cancer.
Journal: Cell discovery
Published: June 05, 2025
m6A-modified Mid1 promotes sevoflurane-induced cognitive impairment in neonatal mice by ubiquitin-mediated degradation of Syngap1.
Journal: Experimental & molecular medicine
Published: April 25, 2025
Therapeutic targeting of YOD1 disrupts the PAX-FOXO1/N-Myc feedback loop in rhabdomyosarcoma.
Journal: JCI insight
Published: March 11, 2025
Metabolomics and metabolites in cancer diagnosis and treatment.
Journal: Molecular biomedicine
Published: January 07, 2025
Auto-RapTAC: A Versatile and Sustainable Platform for the Automated Rapid Synthesis and Evaluation of PROTAC.
Journal: Journal of medicinal chemistry
Published: January 04, 2025
Last Updated: 09/26/2026